Home / Mumbai / Mumbai News / Article /
Mumbai's Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year
Updated On: 17 April, 2021 08:47 AM IST | Mumbai | PTI
A top official said the state-run company is targeting to produce 22.8 crore vials of the vaccine per year.

A frontline worker gets a Covaxin shot at JJ Hospital in south Mumbai. File pic
After receiving permission to make Bharat Biotech's COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical on Friday said it would take least at one year's time for the company to start actual production.
The Dept of Science & Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon’ble PM Shri @narendramodi for approving this request.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

